-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Joshua Johnson, PharmD, BCGP

Articles by Joshua Johnson, PharmD, BCGP

Association of the MedWise Risk Score With Health Care Outcomes

ByVeronique Michaud, BPharm, PhD,Matt K. Smith, PhD,Ravil Bikmetov, PhD,Pamela Dow, MS,Joshua Johnson, PharmD, BCGP,Alan Stein, MD, PhD,Stephanie Finnel, PhD,Huaichuan Jin, MS,Jacques Turgeon, BPharm, PhD

September 16th 2021

Medication-Related Problems Identified by Pharmacists in an Enhanced Medication Therapy Management Model

ByDavid Bankes, PharmD, BCGP,Katie Pizzolato, PharmD,Stephanie Finnel, PhD,Michael S. Awadalla, PharmD, BCGP,Alan Stein, MD, PhD,Joshua Johnson, PharmD, BCGP,Jacques Turgeon, BPharm, PhD

September 16th 2021

Health Outcomes From an Innovative Enhanced Medication Therapy Management Model

ByAlan Stein, MD, PhD,Stephanie Finnel, PhD,David Bankes, PharmD, BCGP,Huaichuan Jin, MS,Michael S. Awadalla, PharmD, BCGP,Joshua Johnson, PharmD, BCGP,Jacques Turgeon, BPharm, PhD

September 16th 2021

Latest Updated Articles

Medication-Related Problems Identified by Pharmacists in an Enhanced Medication Therapy Management Model
September 16th 2021
Association of the MedWise Risk Score With Health Care Outcomes
September 16th 2021
Health Outcomes From an Innovative Enhanced Medication Therapy Management Model
September 16th 2021

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS